144 related articles for article (PubMed ID: 11838626)
1. Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia.
Hofer A; Kemmler G; Eder U; Honeder M; Hummer M; Fleischhacker WW
J Clin Psychiatry; 2002 Jan; 63(1):49-53. PubMed ID: 11838626
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
[TBL] [Abstract][Full Text] [Related]
3. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
[TBL] [Abstract][Full Text] [Related]
4. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.
Freudenreich O; Cather C; Evins AE; Henderson DC; Goff DC
J Clin Psychiatry; 2004 Oct; 65(10):1372-6. PubMed ID: 15491241
[TBL] [Abstract][Full Text] [Related]
5. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
[TBL] [Abstract][Full Text] [Related]
6. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.
Widschwendter CG; Kemmler G; Rettenbacher MA; Yalcin-Siedentopf N; Hofer A
BMC Psychiatry; 2018 Jun; 18(1):212. PubMed ID: 29954366
[TBL] [Abstract][Full Text] [Related]
7. Subjective response to antipsychotics in schizophrenic patients: clinical implications and related factors.
Cabeza IG; Amador MS; López CA; González de Chávez M
Schizophr Res; 2000 Jan; 41(2):349-55. PubMed ID: 10708344
[TBL] [Abstract][Full Text] [Related]
8. Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia.
Campbell AH; Scalo JF; Crismon ML; Barner JC; Argo TR; Lawson KA; Miller A
Clin Schizophr Relat Psychoses; 2018; 12(1):12-22. PubMed ID: 26218237
[TBL] [Abstract][Full Text] [Related]
9. [Quality of life in patients with schizophrenia: a study of 100 cases].
Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic resolution among Chinese patients with schizophrenia and associated factors.
Li CT; Su TP; Chou YH; Lee YC; Liu ME; Ku HL; Shan IK; Bai YM
J Formos Med Assoc; 2010 May; 109(5):378-88. PubMed ID: 20497871
[TBL] [Abstract][Full Text] [Related]
11. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
[TBL] [Abstract][Full Text] [Related]
12. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
[TBL] [Abstract][Full Text] [Related]
13. Attitudes toward antipsychotic medication, insight and psychopathology in outpatients with schizophrenia.
Vassileva IV; Milanova VK
Folia Med (Plovdiv); 2012; 54(4):62-8. PubMed ID: 23441471
[TBL] [Abstract][Full Text] [Related]
14. Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder.
Hofer A; Rettenbacher MA; Widschwendter CG; Kemmler G; Hummer M; Fleischhacker WW
Eur Arch Psychiatry Clin Neurosci; 2006 Jun; 256(4):246-55. PubMed ID: 16311896
[TBL] [Abstract][Full Text] [Related]
15. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
[TBL] [Abstract][Full Text] [Related]
16. Attitudes of patients with schizophrenia toward placebo-controlled clinical trials.
Hummer M; Holzmeister R; Kemmler G; Eder U; Hofer A; Kurzthaler I; Oehl M; Weiss E; Fleischhacker WW
J Clin Psychiatry; 2003 Mar; 64(3):277-81. PubMed ID: 12716268
[TBL] [Abstract][Full Text] [Related]
17. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
[TBL] [Abstract][Full Text] [Related]
18. Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia.
Rocca P; Crivelli B; Marino F; Mongini T; Portaleone F; Bogetto F
Compr Psychiatry; 2008; 49(2):170-6. PubMed ID: 18243890
[TBL] [Abstract][Full Text] [Related]
19. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
[TBL] [Abstract][Full Text] [Related]
20. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G;
Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
